Yun-Jung Choi

This inventor holds 9 USPTO granted patents and 11 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Cymabay Therapeutics, Inc., Discover, LLC. Active years: 2007-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yun-Jung Choi. Retrieved from https://idiyas.com/inventor/yun-jung-choi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 (Patent Applications = 11)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 3 (Patent Applications = 5)

Average Co-Inventor Count = 5.6

ph-index = 4

Forward Citations = 73(Granted Patents)

Company Filing History:

8 out of 43

Cymabay Therapeutics, Inc.

Years Active: 2007-2021

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11179359 - Treatment of NAFLD and NASH (2021-11-23),

2. 11007162 - Methods of reducing small, dense LDL particles (2021-05-18),

3. 10722483 - Treatment of NAFLD and NASH (2020-07-28),

4. 10342770 - Treatment of NAFLD and NASH (2019-07-09),

5. 10188620 - Treatment for NAFLD and NASH (2019-01-29),

6. 9962346 - Treatment of NAFLD and NASH (2018-05-08),

7. 9616039 - Treatment of NAFLD and NASH (2017-04-11),

8. 9381181 - Treatment of NAFLD and NASH (2016-07-05),

9. 7202043 - Detecting cell membrane protein endocytosis (2007-04-10),

Title: **Yun-Jung Choi: Innovator in Medical Treatments**

Introduction

Yun-Jung Choi is a prominent inventor located in Fremont, CA, who has made significant contributions to the field of medical treatments. With an impressive portfolio of nine patents, he has focused his innovations on crucial health issues, including the treatment of liver diseases and the modification of cholesterol particles.

Latest Patents

Among his latest patents, Yun-Jung Choi has developed therapies for the treatment of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). His patent specifically addresses the treatment using MBX-8025 or its salt variants. Additionally, he has invented methods aimed at reducing small, dense low-density lipoprotein (LDL) particles, providing effective strategies for increasing LDL particle size, an important factor in cardiovascular health.

Career Highlights

Yun-Jung Choi has had a noteworthy career, working with esteemed organizations such as Cymabay Therapeutics, Inc. and Discover, LLC. His work in these companies has enabled him to contribute to the advancement of therapeutic solutions in the medical field.

Collaborations

Throughout his career, Choi has collaborated with fellow researchers and inventors, including Xueyan Wang and David Brian Karpf. These collaborations have allowed for the exchange of ideas and techniques that further enhance the innovation in his work.

Conclusion

Yun-Jung Choi stands out as a key inventor in the medical field, demonstrating a strong commitment to developing innovative treatments for prevalent health issues. His patents not only reflect his ingenuity but also contribute to the ongoing quest for medical advancements that can improve patient outcomes.

Profile summary based on public USPTO records.